The generic drug trilemma

Daniel J. Hemel, Lisa Larrimore Ouellette

Year of publication:	2023
Authors:	Hemel, Daniel J. ; Ouellette, Lisa Larrimore
Published in:	Entrepreneurship and innovation policy and the economy : EIPE. - Getzville, NY : HeinOnline, ISSN 2771-1676, ZDB-ID 3121436-8. - Vol. 2.2023, p. 41-77
Subject:	drug pricing \| drug quality \| drug shortages \| generics \| pharmaceutical manufacturing \| pharmaceutical policy \| Arzneimittel \| Pharmaceuticals \| Generika \| Generic drugs \| Arzneimittelmarkt \| Pharmaceutical market \| Pharmaindustrie \| Pharmaceutical industry \| Preis \| Price \| Arzneimittelrecht \| Pharmaceutical law \| Preisregulierung \| Price regulation \| Drogenkonsum \| Drug consumption \| Pharmakologie \| Pharmacology \| Gesundheitspolitik \| Health policy \| Preiswettbewerb \| Price competition \| Produktqualität \| Product quality \| Gesundheitskosten \| Health care costs

Type of publication:	Article
Type of publication (narrower categories):	Aufsatz in Zeitschrift ; Article in journal
Language:	English
Other identifiers:	10.1086/723235 [DOI]
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10015049953